You're signed outSign in or to get full access.
Sand Grove Capital Management LLP
Sand Grove Capital Management LLP is a London-based investment firm, registered in England and Wales, that serves as an investment manager for funds and clients globally. The firm focuses on alternative asset management strategies and, according to regulatory filings, manages investment portfolios across various asset classes. The employee count and client base are not specified in public filings.
Investment Strategy
Sand Grove Capital Management LLP acts as an investment manager for structured opportunities and alternative assets. Their regulatory filings indicate management of diversified, multi-asset portfolios, with likely focus on event-driven, credit, and arbitrage strategies, although public details on specific investment philosophy are limited.
Latest 13F Filing Activity
Sand Grove Capital Management LLP filed their most recent 13F report on Jun 30, 2025 disclosing 10 equity positions with a total 13F market value of $199M. The fund increased holdings in Blueprint Medicines Corp., Springworks Therapeutics Inc., Couchbase Inc. among other positions. Sand Grove Capital Management LLP reduced exposure to Frontier Communications Pare, Hess Corp., Spirit Aerosystems HLDGS Inc. among others.
Top Holdings
Equity Positions (10)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A AMED | AMEDISYS INC | 15.27% | $30.3M | 308,254 | $94.73 | $98.39 | +$12.2M |
B BPMC | BLUEPRINT MEDICINES CORP | 13.62% | $27.1M | 211,124 | $128.18 | $128.18 | +$27.1M |
S SWTX | SPRINGWORKS THERAPEUTICS INC | 13.54% | $26.9M | 572,392 | $46.99 | $46.99 | +$26.9M |
B BASE | COUCHBASE INC | 9.79% | $19.4M | 797,736 | $24.38 | $24.38 | +$19.4M |
H HES | HESS CORP | 8.98% | $17.8M | 128,726 | $149.60 | $138.54 | -$17.8M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more